Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

1.

The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events.

Redon J.

High Blood Press Cardiovasc Prev. 2013 Mar;20(1):13-8. doi: 10.1007/s40292-013-0006-3. Epub 2013 Mar 27. Review.

PMID:
23532740
[PubMed - indexed for MEDLINE]
2.
3.

Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.

Parati G, Schumacher H.

Hypertens Res. 2014 Mar;37(3):187-93. doi: 10.1038/hr.2013.145. Epub 2013 Dec 5. Review.

PMID:
24305518
[PubMed - indexed for MEDLINE]
4.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

Chrysant SG, Germino FW, Neutel JM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):375-89. doi: 10.2165/11636080-000000000-00000. Review.

PMID:
23116225
[PubMed - indexed for MEDLINE]
6.

[Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].

Lou LM, Gimeno JA, Gómez Sánchez R, Labrador T, Beguer P, Lou MT, Boned B, Aguilar E.

Nefrologia. 2002;22(2):179-89. Spanish.

PMID:
12085419
[PubMed - indexed for MEDLINE]
7.

Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.

White WB, Weber MA, Davidai G, Neutel JM, Bakris GL, Giles T.

Blood Press Monit. 2005 Jun;10(3):157-63.

PMID:
15923818
[PubMed - indexed for MEDLINE]
8.

Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring.

Mancia G, Parati G.

Curr Hypertens Rep. 2006 Aug;8(4):330-7. Review.

PMID:
16884665
[PubMed - indexed for MEDLINE]
9.
10.

Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.

Hermida RC, Ayala DE, Fernández JR, Mojón A.

Chronobiol Int. 2013 Mar;30(1-2):68-86. doi: 10.3109/07420528.2012.702581. Epub 2012 Oct 25.

PMID:
23181592
[PubMed - indexed for MEDLINE]
11.

2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.

International Society for Chronobiology; American Association of Medical Chronobiology and Chronotherapeutics; Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk; Spanish Society of Atherosclerosis; Romanian Society of Internal Medicine, Hermida RC, Smolensky MH, Ayala DE, Portaluppi F.

Chronobiol Int. 2013 Apr;30(3):355-410. doi: 10.3109/07420528.2013.750490.

PMID:
23517220
[PubMed - indexed for MEDLINE]
12.

A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.

Lacourcière Y, Neutel JM, Davidai G, Koval S.

Am J Hypertens. 2006 Jan;19(1):104-12.

PMID:
16461201
[PubMed - indexed for MEDLINE]
13.

Optimizing blood pressure control in hypertension: the need to use ABPM.

Schmieder RE, Lehmann MV, Schmidt S.

Blood Press. 2013 Apr;22(2):65-72. doi: 10.3109/08037051.2012.727253. Epub 2012 Oct 4. Review.

PMID:
23035939
[PubMed - indexed for MEDLINE]
14.

Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.

Shimada K, Ogihara T, Saruta T, Kuramoto K; REZALT Study Group.

Clin Ther. 2010 May;32(5):861-81. doi: 10.1016/j.clinthera.2010.04.020.

PMID:
20685495
[PubMed - indexed for MEDLINE]
15.

[Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis].

Kuriyama S, Otsuka Y, Iida R, Kobayashi S, Yamagishi H, Hosoya T.

Nihon Jinzo Gakkai Shi. 2005;47(1):38-45. Japanese.

PMID:
15754762
[PubMed - indexed for MEDLINE]
16.

A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.

Ulusoy S, Ozkan G, Konca C, Kaynar K.

Hypertens Res. 2012 Nov;35(11):1111-7. doi: 10.1038/hr.2012.95. Epub 2012 Jul 12.

PMID:
22786565
[PubMed - indexed for MEDLINE]
17.

Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality.

Verdecchia P, Clement D, Fagard R, Palatini P, Parati G.

Blood Press Monit. 1999 Dec;4(6):303-17. Review.

PMID:
10602535
[PubMed - indexed for MEDLINE]
18.

[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].

Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.

Rev Port Cardiol. 1999 Oct;18(10):897-906. Portuguese.

PMID:
10590654
[PubMed - indexed for MEDLINE]
19.

Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.

Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.

Clin Ther. 2004 Sep;26(9):1436-45.

PMID:
15531006
[PubMed - indexed for MEDLINE]
20.

Importance of aggressive blood pressure lowering when it may matter most.

White WB.

Am J Cardiol. 2007 Aug 6;100(3A):10J-16J. Epub 2007 May 25. Review.

PMID:
17666192
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk